BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
New formulation of rhGH from Alkermes and Genentech
July 12, 1996
KGR-1380: A novel glycation inhibitor
July 12, 1996
Aldose reductase inhibitors described by Grelan
July 12, 1996
Optro enters U.S./Canadian phase II trials
July 12, 1996
Pharmacia & Upjohn terminates Hemopure codevelopment agreement
July 12, 1996
Results of fat accumulation/PAI-1 levels relationship study disclosed
July 12, 1996
Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb
July 12, 1996
(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor
July 12, 1996
Pfizer and Warner-Lambert sign atorvastatin agreement
July 12, 1996
Cathepsin B and L inhibitors in Fujisawa's pipeline
July 12, 1996
Previous
1
2
…
1768
1769
1770
1771
1772
1773
1774
1775
1776
…
1788
1789
Next
RSS